{'fraction_non_alphanumeric': 0.03785488958990536, 'fraction_numerical': 0.017350157728706624, 'mean_word_length': 4.990566037735849, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2‐10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in China

The performance of prostate health index (phi) in predicting prostate biopsy outcomes has been well established for patients with prostate‐specific antigen (PSA) values between 2 and 10 ng/mL. However, the performance of phi remains unknown in patients with PSA >10 ng/mL, the vast majority in Chinese biopsy patients. We aimed to assess the ability of phi to predict prostate cancer (PCa) and high‐grade disease (Gleason Score ≥7) on biopsy in a Chinese population.